Centratex

Product NDC

23359-100

Requested package NDC

23359-100-30

11-digit product format

233590100

Labeler code

23359

Product ID

23359-100_d57e8568-b7e7-739b-e053-2a95a90a5edd

Type

HUMAN PRESCRIPTION DRUG

Nonproprietary name

Iron, Sodium Ascorbate, Thiamine Mononitrate, Riboflavin, Pyridoxine Hydrochloride, Folic Acid, Cyanocobalamin, Niacinamide, Calcium Pantothenate, Zinc Sulfate, Magnesium Sulfate, Manganese Sulfate, and Cupric Sulfate Anhydrous

Dosage form

CAPSULE

Route

ORAL

Labeler

Centurion Labs, LLC

Marketing category

UNAPPROVED DRUG OTHER

Marketing start

2009-06-14

Marketing end

0000-00-00

Substance

IRON; SODIUM ASCORBATE; THIAMINE MONONITRATE; RIBOFLAVIN; PYRIDOXINE HYDROCHLORIDE; FOLIC ACID; CYANOCOBALAMIN; NIACINAMIDE; CALCIUM PANTOTHENATE; ZINC SULFATE; MAGNESIUM SULFATE, UNSPECIFIED; MANGANESE SULFATE; CUPRIC SULFATE ANHYDROUS

Active strength

106 mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1

Pharmacologic classes

Vitamin C [EPC],Ascorbic Acid [CS],Vitamin B6 Analog [EPC],Vitamin B 6 [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient],Vitamin B 12 [CS],Vitamin B12 [EPC],Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Calcium [CS],Cations, Divalent [CS],Copper Absorption Inhibitor [EPC],Decreased Copper Ion Absorption [PE],Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Osmotic Laxative [EPC],Osmotic Activity [MoA],Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],Increased Large Intestinal Motility [PE],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Magnetic Resonance Contrast Activity [MoA],Paramagnetic Contrast Agent [EPC]

NDC exclude flag

No

Listing certified through

2023-12-31

Current FDA listing

Historical FDA.report record